Emergent Cost Of Revenue from 2010 to 2025
| EBS Stock | USD 5.73 0.01 0.17% |
Cost Of Revenue | First Reported 2004-03-31 | Previous Quarter 129.6 M | Current Value 118 M | Quarterly Volatility 68.5 M |
Check Emergent Biosolutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent Biosolutions' main balance sheet or income statement drivers, such as Depreciation And Amortization of 114.2 M, Interest Expense of 74.5 M or Total Revenue of 583.9 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.018 or PTB Ratio of 1.0. Emergent financial statements analysis is a perfect complement when working with Emergent Biosolutions Valuation or Volatility modules.
Emergent | Cost Of Revenue |
Latest Emergent Biosolutions' Cost Of Revenue Growth Pattern
Below is the plot of the Cost Of Revenue of Emergent Biosolutions over the last few years. Cost of Revenue is found on Emergent Biosolutions income statement and represents the costs associated with goods and services Emergent Biosolutions provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Emergent Biosolutions' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Emergent Biosolutions' overall financial position and show how it may be relating to other accounts over time.
| Cost Of Revenue | 10 Years Trend |
|
Cost Of Revenue |
| Timeline |
Emergent Cost Of Revenue Regression Statistics
| Arithmetic Mean | 286,285,813 | |
| Geometric Mean | 19,662,468 | |
| Coefficient Of Variation | 93.74 | |
| Mean Deviation | 232,062,414 | |
| Median | 195,707,000 | |
| Standard Deviation | 268,361,324 | |
| Sample Variance | 72017.8T | |
| Range | 757.5M | |
| R-Value | 0.35 | |
| Mean Square Error | 67544T | |
| R-Squared | 0.12 | |
| Significance | 0.18 | |
| Slope | 19,900,543 | |
| Total Sum of Squares | 1080267T |
Emergent Cost Of Revenue History
About Emergent Biosolutions Financial Statements
Emergent Biosolutions shareholders use historical fundamental indicators, such as Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Emergent Biosolutions investors may analyze each financial statement separately, they are all interrelated. The changes in Emergent Biosolutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on Emergent Biosolutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 1.00 | 0.95 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Emergent Stock Analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.